![Jude Onyia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jude Onyia
Chief Tech/Sci/R&D Officer at
NEUROCRINE BIOSCIENCES, INC.
Net worth: 4 M $ as of 2026-06-29
Profile
Currently, Jude Onyia is Director at Voyager Therapeutics, Inc. since 2023 and Chief Scientific Officer at Neurocrine Biosciences, Inc. since 2021.
Formerly, Dr. Onyia was Vice President-Biotechnology Discovery Research at Eli Lilly & Co. from 2014 to 2021 and Chief Scientific Officer at Capsida Biotherapeutics, Inc. in 2021.
Education includes a doctorate from State University of New York at Downstate Medical Center, an undergraduate degree from Suny College of Environmental Science & Forestry, and a doctorate from SUNY Upstate Medical University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-03 | 20,996 ( 0.02% ) | 4 M $ | 2026-06-29 | |
| 2026-06-08 | 2,910 ( 0% ) | 10 185 $ | 2026-06-29 |
Jude Onyia active positions
| Companies | Position | Start |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-11-29 |
| VOYAGER THERAPEUTICS, INC. | Director/Board Member | 2023-02-20 |
Former positions of Jude Onyia
| Companies | Position | End |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Chief Tech/Sci/R&D Officer | 2021-10-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2021-05-31 |
Training of Jude Onyia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
SUNY College of Environmental Science
 SUNY College of Environmental Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
- Stock Market
- Insiders
- Jude Onyia
